188 related articles for article (PubMed ID: 8642863)
1. Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.
Backx B; Broeders L; Hoefsloot LH; Wognum B; Löwenberg B
Leukemia; 1996 Mar; 10(3):466-72. PubMed ID: 8642863
[TBL] [Abstract][Full Text] [Related]
2. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].
Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866
[TBL] [Abstract][Full Text] [Related]
3. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes.
Merchav S; Nielsen OJ; Rosenbaum H; Sharon R; Brenner B; Tatarsky I; Scigalla P; Wieczorek L
Leukemia; 1990 Nov; 4(11):771-4. PubMed ID: 2232891
[TBL] [Abstract][Full Text] [Related]
5. Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome.
Backx B; Broeders L; Löwenberg B
Blood; 1992 Sep; 80(5):1213-7. PubMed ID: 1381239
[TBL] [Abstract][Full Text] [Related]
6. Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction.
Fontenay-Roupie M; Bouscary D; Guesnu M; Picard F; Melle J; Lacombe C; Gisselbrecht S; Mayeux P; Dreyfus F
Br J Haematol; 1999 Aug; 106(2):464-73. PubMed ID: 10460607
[TBL] [Abstract][Full Text] [Related]
7. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.
Musto P; Modoni S; Alicino G; Savino A; Longo A; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G
Haematologica; 1994; 79(6):493-9. PubMed ID: 7896207
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of Kit and the receptors for erythropoietin, interleukin 6 and GM-CSF on hemopoietic cells.
de Jong MO; Westerman Y; Wagemaker G; Wognum AW
Stem Cells; 1997; 15(4):275-85. PubMed ID: 9253111
[TBL] [Abstract][Full Text] [Related]
9. Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients.
Follo MY; Mongiorgi S; Clissa C; Paolini S; Martinelli G; Martelli AM; Fioravanti G; Manzoli L; Finelli C; Cocco L
Leukemia; 2012 Dec; 26(12):2474-82. PubMed ID: 22596089
[TBL] [Abstract][Full Text] [Related]
10. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
[TBL] [Abstract][Full Text] [Related]
11. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
[TBL] [Abstract][Full Text] [Related]
12. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
13. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
[TBL] [Abstract][Full Text] [Related]
14. Role of c-Kit and erythropoietin receptor in erythropoiesis.
Munugalavadla V; Kapur R
Crit Rev Oncol Hematol; 2005 Apr; 54(1):63-75. PubMed ID: 15780908
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of c-kit receptor in bone marrow mononuclear cells of patients with myelodysplastic syndromes.
Shao Z; Zhang H; Chen G; Wang L; Li K; Zhang Y; Li L; Sun J
Chin Med J (Engl); 2001 May; 114(5):481-5. PubMed ID: 11780408
[TBL] [Abstract][Full Text] [Related]
16. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
Backx B; Broeders L; Touw I; Löwenberg B
Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
[TBL] [Abstract][Full Text] [Related]
17. Disparate regulation of human fetal erythropoiesis by the microenvironments of the liver and bone marrow.
Muench MO; Namikawa R
Blood Cells Mol Dis; 2001; 27(2):377-90. PubMed ID: 11259159
[TBL] [Abstract][Full Text] [Related]
18. [Study of the expression and function of c-kit receptor on the bone marrow mononuclear cells of the patients with myelodysplastic syndromes].
Zhang H; Shao Z; Chen G; Wang L; Zhang Y; Li K; Li L; Sun J; Hao Y
Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):176-8. PubMed ID: 11876975
[TBL] [Abstract][Full Text] [Related]
19. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis.
Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC
Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679
[TBL] [Abstract][Full Text] [Related]
20. A novel way to induce erythroid progenitor self renewal: cooperation of c-Kit with the erythropoietin receptor.
Wessely O; Bauer A; Quang CT; Deiner EM; von Lindern M; Mellitzer G; Steinlein P; Ghysdael J; Beug H
Biol Chem; 1999 Feb; 380(2):187-202. PubMed ID: 10195426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]